Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2022-11-11
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To address these needs, researchers have dedicated several years to developing indirect methodologies notably centered around utilizing markers derived from the host's immune system. Among these, one particularly promising approach focuses on measuring the expression of interferon-stimulated genes, which are uniquely triggered by viral infections, thereby facilitating viral diagnosis. This methodology's efficacy has been proven in the context of SARS-CoV-2 infections.
This study's objective is to assess the functionality of such a tool across a spectrum of Respiratory Viral Infections (RVIs) prevalent within a French population during the winter season.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interferon Reference for Older People - REFIPA Study
NCT07239830
Characterization of the IFN-I Response in Subjects Who Experienced Severe or Mild Forms of COVID-19
NCT06703034
Impact of the Presence of Anti-interferon Autoantibodies on the Viral Load in Severe Respiratory Infections
NCT05536219
Respiratory Virus Infections in Acutely Hospitalized Adult Patients With Pulmonary and Extrapulmonary Complications
NCT03816059
Development and Qualification of Methods for Analyzing the Mucosal Immune Response to COVID-19
NCT06142279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Replicative viruses
Presence of a replicative virus determined by viral culture
Evaluate the performance of IFN I/III
Evaluate the response in diagnosing non-respiratory viral infection.
Unreplicative viruses
Absence of a replicative virus determined by viral culture
Evaluate the performance of IFN I/III
Evaluate the response in diagnosing non-respiratory viral infection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Evaluate the performance of IFN I/III
Evaluate the response in diagnosing non-respiratory viral infection.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Samples kept at the CRB since 2018
* Information to patients carried out and non-objection collected-
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Infective Agents Institute, Croix rousse Hospital
Lyon, Rhone, France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL23_0697
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.